Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559

Barry, 2004, Mesenchymal stem cells: Clinical applications and biological characterization, Int. J. Biochem. Cell Biol., 36, 568, 10.1016/j.biocel.2003.11.001

Batten, 2006, Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves, Tissue Eng., 12, 2263, 10.1089/ten.2006.12.2263

Chamberlain, 2007, Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features and Potential for Homing, Stem Cells, 25, 2739, 10.1634/stemcells.2007-0197

Chen, 2006, Mesenchymal stem cells in immunoregulation, Immunol. Cell Biol., 84, 413, 10.1111/j.1440-1711.2006.01458.x

Dazzi, 2006, The role of mesenchymal stem cells in haemopoiesis, Blood Rev., 20, 161, 10.1016/j.blre.2005.11.002

Devadas, 2006, Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells, Immunity, 25, 237, 10.1016/j.immuni.2006.06.011

Djouad, 2005, Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis, Arthritis Rheum., 52, 1595, 10.1002/art.21012

Edwards, 2007, New perspectives on the mechanisms through which nitric oxide may affect learning and memory processes, Neurosci. Biobehav. Rev., 31, 413, 10.1016/j.neubiorev.2006.11.001

Groh, 2005, Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells, Exp. Hematol., 33, 928, 10.1016/j.exphem.2005.05.002

Hattori, 1998, Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies, Blood, 91, 4051, 10.1182/blood.V91.11.4051

Hoffman, 2002, Differential modulation of CD4 and CD8 T-cell proliferation by induction of nitric oxide synthesis in antigen presenting cells, Transplantation, 74, 836, 10.1097/00007890-200209270-00018

Honczarenko, 2006, Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors, Stem Cells, 24, 1030, 10.1634/stemcells.2005-0319

Inoue, 2006, Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model, Transplantation, 81, 1589, 10.1097/01.tp.0000209919.90630.7b

Jacobsohn, 2002, Novel therapeutics for the treatment of graft-versus-host disease, Expert Opin. Investig. Drugs, 11, 1271, 10.1517/13543784.11.9.1271

Kawada, 2004, Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction, Blood, 104, 3581, 10.1182/blood-2004-04-1488

Keating, 2006, Mesenchymal stromal cells, Curr. Opin. Hematol., 13, 419, 10.1097/01.moh.0000245697.54887.6f

Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH), Bone Marrow Transplant., 30, 215, 10.1038/sj.bmt.1703650

Krampera, 2006, Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells, Stem Cells, 24, 386, 10.1634/stemcells.2005-0008

Lancaster, 1997, A tutorial on the diffusibility and reactivity of free nitric oxide, Nitric Oxide, 1, 18, 10.1006/niox.1996.0112

Lazzeri, 2005, CXCR3-binding chemokines: Novel multifunctional therapeutic targets, Curr. Drug Targets Immune Endocr. Metabol. Disord., 5, 109, 10.2174/1568008053174723

Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7

Le Blanc, 2006, Mesenchymal stem cells: Properties and role in clinical bone marrow transplantation, Curr. Opin. Immunol., 18, 586, 10.1016/j.coi.2006.07.004

Loetscher, 1998, Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization, Eur. J. Immunol., 28, 3696, 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W

Lu, 1996, Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: Current status and future application, Crit. Rev. Oncol. Hematol., 22, 61, 10.1016/1040-8428(96)88370-3

McCarthy, 1991, Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease, Blood, 78, 1915, 10.1182/blood.V78.8.1915.1915

Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909

Meyer, 2001, Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection, Eur. J. Immunol., 31, 2521, 10.1002/1521-4141(200108)31:8<2521::AID-IMMU2521>3.0.CO;2-Q

Miranda, 2001, A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite, Nitric Oxide, 5, 62, 10.1006/niox.2000.0319

Miszta-Lane, 2006, Stem cell sources for clinical islet transplantation in type 1 diabetes: Embryonic and adult stem cells, Med. Hypotheses, 67, 909, 10.1016/j.mehy.2006.03.036

Murad, 2006, Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development, N. Engl. J. Med., 355, 2003, 10.1056/NEJMsa063904

Nauta, 2006, Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting, Blood, 108, 2114, 10.1182/blood-2005-11-011650

Niedbala, 2006, Role of nitric oxide in the regulation of T cell functions, Ann. Rheum. Dis., 65, iii37

Plumas, 2005, Mesenchymal stem cells induce apoptosis of activated T cells, Leukemia, 19, 1597, 10.1038/sj.leu.2403871

Pommey, 2006, The use of mesenchymal stromal cells in oncology and cell therapy, Bull. Cancer, 93, 901

Radvanyi, 1996, Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis, Cell. Immunol., 170, 260, 10.1006/cimm.1996.0160

Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp. Cell Res., 305, 33, 10.1016/j.yexcr.2004.12.013

Ries, 2007, MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: Differential regulation by inflammatory cytokines, Blood, 109, 4055, 10.1182/blood-2006-10-051060

Sato, 2007, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood, 109, 228, 10.1182/blood-2006-02-002246

Schenk, 2007, MCP-3 is a myocardial mesenchymal stem cell homing factor, Stem Cells, 25, 245, 10.1634/stemcells.2006-0293

Shi, 1993, A rapid, multiwell colorimetric assay for chemotaxis, J. Immunol. Methods, 164, 149, 10.1016/0022-1759(93)90307-S

Shlomchik, 2007, Graft-versus-host disease, Nat. Rev. Immunol., 7, 340, 10.1038/nri2000

Stamler, 1992, Biochemistry of nitric oxide and its redox-activated forms, Science, 258, 1898, 10.1126/science.1281928

Sudres, 2006, Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice, J. Immunol., 176, 7761, 10.4049/jimmunol.176.12.7761

Tamada, 2000, Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway, Nat. Med., 6, 283, 10.1038/73136

van Laar, 2006, Adult stem cells in the treatment of autoimmune diseases, Rheumatology (Oxford), 45, 1187, 10.1093/rheumatology/kel158

Vaughn, 1998, Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model, Am. J. Physiol., 274, H2163

Von Luttichau, 2005, Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4, Stem Cells Dev., 14, 329, 10.1089/scd.2005.14.329

Wojakowski, 2005, Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes, Folia Histochem. Cytobiol., 43, 229

Xu, 2007, Immunosuppressive properties of cloned bone marrow mesenchymal stem cells, Cell Res., 17, 240, 10.1038/cr.2007.4

Xu, 2007, The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells, Biochem. Biophys. Res. Commun., 361, 745, 10.1016/j.bbrc.2007.07.052

Xu, 2007, Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease, Blood, 109, 4097, 10.1182/blood-2006-09-047332

Yang, 1998, Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12, J. Clin. Invest., 102, 2126, 10.1172/JCI4992

Zappia, 2005, Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy, Blood, 106, 1755, 10.1182/blood-2005-04-1496